UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of UCN-01 in treating patients who have
unresectable stage III or stage IV kidney cancer.